Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Daniela Trabattoni Added: 2 years ago
A single centre, prospective, non-randomised study from DrDaniela Trabattoni (Monzino Cardiology Centre,Milan, IT) following device implantation of the Occlutech PFO Closure device in 442 consecutive patients.The study is particularly interesting due to the scarcity of data available on the long term follow up (over 5 years after) of device implantation. Also, the results are focussed not only… View more
Author(s): Saibal Kar , Harriette Van Spall Added: 2 weeks ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk… View more
Author(s): Jens Erik Nielsen Kudsk , Added: 1 month ago
Intracardiac echocardiography (ICE) has undergone a profound transformation in its role within left atrial appendage (LAA) closure – evolving from an experimental imaging adjunct to a clinically validated and increasingly adopted guidance strategy.In this on-demand educational discussion, Prof Jens Erik Nielsen-Kudsk (Aarhus University Hospital, DK) and Dr Sergio Berti (Fondazione Toscana G… View more
Author(s): Sean Lyden Added: 1 year ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more